Skip to search formSkip to main contentSkip to account menu

recurrent neuroblastoma

Known as: Relapsed Neuroblastoma, neuroblastoma, recurrent 
The reemergence of neuroblastoma after a period of remission.
National Institutes of Health

Related topics

Related topics

15 relations
Embryonic CellEmbryonic tissueHemorrhageLoss of Chromosome 1p

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Iodine‐131‐metaiodobenzylguanidine therapy with reduced‐intensity allogeneic stem cell transplantation in recurrent neuroblastoma
Neuroblastoma is the most common extracranial solid tumor of childhood, and iodine‐131‐metaiodobenzylguanidine (MIBG) therapy is… 
2005
2005
One‐ and two‐stage designs for stratified phase II clinical trials
A global one‐sample test for response rates for stratified phase II clinical trials is proposed. Such a test is analogous to that… 
2003
2003
Oral Topotecan for Refractory and Relapsed Neuroblastoma: A Retrospective Analysis
Purpose: Among patients with multiply relapsed neuroblastoma refractory to conventional chemotherapy, oral topotecan has often… 
2003
2003
Successful clinical response to irinotecan in relapsed neuroblastoma.
2002
2002
Linkage Analysis in Families with Recurrent Neuroblastoma
Abstract: Neuroblastoma is a neural crest‐derived tumor of childhood with a serious prognosis; only 20% of patients with stage 4… 
Highly Cited
1998
Highly Cited
1998
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer…
The antitumor activity of topotecan administered as a 72-h continuous i.v. infusion was evaluated in children with refractory… 
Highly Cited
1991
Highly Cited
1991
Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases.
From October 1984 to November 1987, 34 patients aged from 1 year 1 month to 7 years 7 months with resistant or relapsed… 
1987
1987
Resistant and relapsing neuroblastoma: improved response rate with a new multiagent regimen (OC-HDP) including high-dose cisplatinum.
From September 1984 to July 1985, 11 children from 6 months to 6 years of age were treated with a three-drug regimen (OC-HDP… 
1987
1987
High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II study.
Seven children with neuroblastoma who had relapsed on or after conventional therapy (3 originally stage IV, 3 stage III, 1 stage… 
Highly Cited
1984
Highly Cited
1984
High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma.
Neuroblastoma and Ewing's sarcoma are examples of pediatric cancers in which disseminated disease is often present at diagnosis… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)